官方服务：
资源简介：
Study of effect of RUNX1 mutations on lower-risk MDS patients
应用场景：
创建时间：
2022-01-31
相关数据集
Molecular Genetics of Secondary Histiocytic/Dendritic Sarcoma. Molecular Genetics of Secondary Histiocytic/Dendritic Sarcoma
This is a comprehensive genomic analysis of a rare set of secondary histiocytic/dendritic sarcomas from the consult service of the Hematopathology section of the Laboratory of Pathology, NCI, NIH.
NIAID Data Ecosystem50
Table_1_Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome.docx
Despite the improvements in prognostication of the revised International Prognostic Scoring System (IPSS-R) in myelodysplastic syndrome (MDS), there remain a portion of patients with lower risk (low/i
NIAID Data Ecosystem40
Recurrent CNAs reported by previous studies of MDS/AML and this study.
Recurrent CNAs reported by previous studies of MDS/AML and this study.
Figshare2016-10-31 更新40
SNPs Array Karyotyping Reveals a Novel Recurrent 20p13 Amplification in Primary Myelofibrosis
The molecular pathogenesis of primary mielofibrosis (PMF) is still largely unknown. Recently, single-nucleotide polymorphism arrays (SNP-A) allowed for genome-wide profiling of copy-number alterations
NIAID Data Ecosystem50
Sézary Syndrome Originates from Heavily Mutated Hematopoietic Progenitors
The pathogenesis of cutaneous T cell lymphoma (CTCL) remains unclear. To study the malignant transformation of CTCL, we collected matched hematopoietic stem cell (HSC) extracts from bone marrow, CD4+C
NIAID Data Ecosystem40
